Dual inhibition of PKC and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma

被引：0
|
作者：
Carita, Guillaume
Leitz, Estelle Frisch Dit
Dahmani, Ahmed
Raymondie, Chloe
Cassoux, Nathalie
Piperno-Neumann, Sophie
Nemati, Fariba
Halilovic, Ensar
Jeay, Sebastien
Wylie, Andrew
Emery, Caroline
Roman-Roman, Sergio
Schoumacher, Marie
Decaudin, Didier
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3027
引用
收藏
页数：3
相关论文
共 44 条
  • [1] Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma
    Carita, G.
    Frisch-Dit-Leitz, E.
    Dahmani, A.
    Raymondie, C.
    Cassoux, N.
    Piperno-Neumann, S.
    Nemati, F.
    Laurent, C.
    De Koning, L.
    Halilovic, E.
    Jeay, S.
    Wylie, A.
    Emery, C.
    Roman-Roman, S.
    Schoumacher, M.
    Decaudin, D.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S31 - S31
  • [2] Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma
    Carita, Guillaume
    Frisch-Dit-Leitz, Estelle
    Dahmani, Ahmed
    Raymondie, Chloe
    Cassoux, Nathalie
    Piperno-Neumann, Sophie
    Nemati, Fariba
    Laurent, Cecile
    De Koning, Leanne
    Halilovic, Ensar
    Jeay, Sebastien
    Wylie, Andrew
    Emery, Caroline
    Roman-Roman, Sergio
    Schoumacher, Marie
    Decaudin, Didier
    ONCOTARGET, 2016, 7 (23) : 33542 - 33556
  • [3] PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells
    Davies, L.
    Spiller, D.
    White, M. R. H.
    Grierson, I.
    Paraoan, L.
    CELL DEATH & DISEASE, 2011, 2 : e136 - e136
  • [4] PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells
    L Davies
    D Spiller
    M R H White
    I Grierson
    L Paraoan
    Cell Death & Disease, 2011, 2 : e136 - e136
  • [5] CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells
    Togashi, Keita
    Suzuki, Shuhei
    Mitobe, Yuta
    Nakagawa-Saito, Yurika
    Sugai, Asuka
    Takenouchi, Senri
    Sugimoto, Masahiko
    Kitanaka, Chifumi
    Okada, Masashi
    CANCERS, 2024, 16 (01)
  • [6] Inhibition of p53-MDM2 protein interaction reduces tumor growth in a mouse melanoma model.
    Ingelshed, Katrine
    Lianoudaki, Danai
    Lama, Dilraj
    Sohn, Silke
    Fritz, Nicolas
    Jiang, Long
    Wermeling, Fredrik
    Karlsson, Mikael
    Lane, David P.
    Sedimbi, Saikiran K.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 71 - 71
  • [7] The p53-MDM2 interaction in a cancer-prone family, and the identification of a novel therapeutic target
    Picksley, SM
    Spicer, JF
    Barnes, DM
    Lane, DP
    ACTA ONCOLOGICA, 1996, 35 (04) : 429 - 434
  • [8] DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties
    Soares, Joana
    Espadinha, Margarida
    Raimundo, Liliana
    Ramos, Helena
    Gomes, Ana Sara
    Gomes, Sara
    Loureiro, Joana B.
    Inga, Alberto
    Reis, Flavio
    Gomes, Celia
    Santos, Maria M. M.
    Saraiva, Lucilia
    MOLECULAR ONCOLOGY, 2017, 11 (06): : 612 - 627
  • [9] Phosphorylation of TSC2 by PKC-δ reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity
    Zhan, Jun
    Chitta, Raghu K.
    Harwood, Frank C.
    Grosveld, Gerard C.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2019, 456 (1-2) : 123 - 134
  • [10] Phosphorylation of TSC2 by PKC-δ reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity
    Jun Zhan
    Raghu K. Chitta
    Frank C. Harwood
    Gerard C. Grosveld
    Molecular and Cellular Biochemistry, 2019, 456 : 123 - 134
12345